Skip to main content

Peer Review reports

From: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]

Original Submission
4 Feb 2022 Submitted Original manuscript
24 Feb 2022 Reviewed Reviewer Report - Kirsty Loudon
17 Mar 2022 Author responded Author comments - Xuan Ying Poh
Resubmission - Version 2
17 Mar 2022 Submitted Manuscript version 2
23 Apr 2022 Editorially accepted
16 Jun 2022 Article published 10.1186/s13063-022-06345-2

You can find further information about peer review here.

Back to article page